Data search
Results for MligTC455_56624
| Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
|---|---|---|---|---|---|---|
| MligTC455_56624 | 8 | 0.17 | Mlig455_034946 | Neo: - Age: - |
Mlig455_034946 {REF} {Length: 329} {NoTransDecoderORF} {RNA1310_78916} {RNA815_63138} |
Cumulative graph for MligTC455_56624
Region-enriched expression
| Region | logFC | logCPM | Pvalue | FDR | Specificity |
|---|---|---|---|---|---|
| RegionR1 | - | - | - | - | |
| RegionR2 | - | - | - | - | |
| RegionR3 | - | - | - | - | |
| RegionR4 | - | - | - | - | |
| RegionR5 | - | - | - | - | |
| RegionR6 | - | - | - | - | |
| RegionR7 | - | - | - | - | |
| RegionR8 | - | - | - | - |
Regeneration-enriched expression
| Region | logFC | logCPM | PValue | FDR | Specificity |
|---|---|---|---|---|---|
| RegenerationR1 | - | - | - | - | |
| RegenerationR2 | - | - | - | - | |
| RegenerationR3 | - | - | - | - | |
| RegenerationR4 | - | - | - | - | |
| RegenerationR5 | - | - | - | - | |
| RegenerationR6 | - | - | - | - | |
| RegenerationBL | - | - | - | - | |
| RegenerationTP | - | - | - | - |
Genes with expression patterns similar to MligTC455_56624
| Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | MligTC455_56624 | 8 | 0.17 | Mlig455_034946 | Neo: - Age: - |
1 | - | - | - | - | 1.000 | - | Mlig455_034946 {REF} {Length: 329} {NoTransDecoderORF} {RNA1310_78916} {RNA815_63138} | |
| 2. | MligTC455_11279 | 35 | 0.73 | Mlig455_013960 | Neo: - Age: - |
ANK1 | 0.995 | - | - | - | - | 0.995 | - | Mlig455_013960 {REF} {Length: 3851} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=175.9]; Ankyrin repeats (many copies) [PF13637.8, score=158.1]; Ankyrin repeats (many copies) [PF13857.8, score=137.2]; Ankyrin repeat [PF00023.32, score=134.2]; Ankyrin repeat [PF13606.8, score=115.0]; Mab-21 protein [PF03281.16, score=28.0]} {Human: ENSG00000029534, ANK1, ankyrin 1, [Score=171, Expect=9e-43]; ENSG00000151458, ANKRD50, ankyrin repeat domain 50, [Score=168, Expect=7e-42]} {Mouse: ENSMUSG00000031543, Ank1, ankyrin 1, erythroid, [Score=173, Expect=1e-43]} {Dmel: FBgn0011747, Ank, Ankyrin, [Score=192, Expect=1e-49]} {Celegans: WBGene00006780, unc-44, AO66 ankyrin, [Score=162, Expect=2e-40]} {Smed: dd_Smed_v6_2072_0_2, dd_Smed_v6_2072_0_2, [Score=150, Expect=9e-37]} |
| 3. | MligTC455_37668 | 16 | 0.32 | Mlig455_056257 | Neo: - Age: - |
0.992 | - | - | - | - | 0.992 | - | Mlig455_056257 {REF} {Length: 2106} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=19.7]} {Smed: dd_Smed_v6_129_2_1, dd_Smed_v6_129_2_1, [Score=86.7, Expect=6e-18]} {RNA1509_42704} {RNA1310_21353.2} {RNA815_9313} | |
| 4. | MligTC455_30845 | 20 | 0.41 | Mlig455_011948 | Neo: - Age: Up-Down-Up |
CRB1 | 0.982 | - | - | - | - | 0.982 | - | Mlig455_011948 {REF} {Length: 2732} {Human: ENSG00000134376, CRB1, crumbs 1, cell polarity complex component, [Score=62.0, Expect=1e-09]} {Mouse: ENSMUSG00000021614, Vcan, versican, [Score=57.0, Expect=3e-08]; ENSMUSG00000014773, Dll1, delta like canonical Notch ligand 1, [Score=54.7, Expect=1e-07]} {Dmel: FBgn0259685, crb, crumbs, [Score=57.0, Expect=2e-08]} {Celegans: WBGene00003001, lin-12, [Score=47.4, Expect=1e-05]} {Smed: dd_Smed_v6_11876_0_1, dd_Smed_v6_11876_0_1, [Score=52.0, Expect=5e-07]} {RNA1509_37192} {RNA1310_27038} {RNA815_4589.1} |
| 5. | MligTC455_00291 | 4 | 0.08 | Mlig455_041817 | Neo: - Age: - |
0.98 | - | - | - | - | 0.980 | - | Mlig455_041817 {REF} {Length: 137} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_50573} {RNA1310_17892.1} | |
| 6. | MligTC455_05640 | 9 | 0.19 | Mlig455_023571 | Neo: - Age: - |
0.978 | - | - | - | - | 0.978 | - | Mlig455_023571 {REF} {Length: 993} {NoTransDecoderORF} | |
| 7. | MligTC455_51667 | 8 | 0.16 | Mlig455_048719 | Neo: - Age: - |
0.976 | - | - | - | - | 0.976 | - | Mlig455_048719 {REF} {Length: 1694} {NoTransDecoderORF} {RNA1310_79624} | |
| 8. | MligTC455_14717 | 4 | 0.09 | Mlig455_052787 | Neo: - Age: - |
0.975 | - | - | - | - | 0.975 | - | Mlig455_052787 {REF} {Length: 355} {RNA1509_43735} {RNA1310_16914} {RNA815_17245} | |
| 9. | MligTC455_00053 | 10 | 0.2 | Mlig455_045698 | Neo: - Age: - |
0.974 | - | - | - | - | 0.974 | - | Mlig455_045698 {REF} {Length: 347} {NoTransDecoderORF} | |
| 10. | MligTC455_51666 | 8 | 0.17 | Mlig455_048609 | Neo: - Age: - |
0.974 | - | - | - | - | 0.974 | - | Mlig455_048609 {REF} {Length: 1581} {NoTransDecoderORF} {RNA1310_79624} | |
| 11. | MligTC455_24612 | 12 | 0.25 | Mlig455_000425, Mlig455_000489, Mlig455_000526, Mlig455_024858 | Neo: - Age: - |
SCN1A | 0.971 | - | - | - | - | 0.971 | - | Mlig455_000425 {REF} {Length: 2186} {Pfam: Ion transport protein [PF00520.33, score=296.1]; Voltage-dependent L-type calcium channel, IQ-associated [PF16905.7, score=31.9]; Polycystin cation channel [PF08016.14, score=23.2]} {Human: ENSG00000144285, SCN1A, sodium voltage-gated channel alpha subunit 1, [Score=502, Expect=4e-157]; ENSG00000136531, SCN2A, sodium voltage-gated channel alpha subunit 2, [Score=498, Expect=2e-156]; ENSG00000169432, SCN9A, sodium voltage-gated channel alpha subunit 9, [Score=490, Expect=7e-153]; ENSG00000153253, SCN3A, sodium voltage-gated channel alpha subunit 3, [Score=486, Expect=2e-151]; ENSG00000183873, SCN5A, sodium voltage-gated channel alpha subunit 5, [Score=486, Expect=9e-152]; ENSG00000196876, SCN8A, sodium voltage-gated channel alpha subunit 8, [Score=481, Expect=1e-149]; ENSG00000007314, SCN4A, sodium voltage-gated channel alpha subunit 4, [Score=481, Expect=4e-150]} {Mouse: ENSMUSG00000064329, Scn1a, sodium channel, voltage-gated, type I, alpha, [Score=500, Expect=7e-157]; ENSMUSG00000001027, Scn4a, sodium channel, voltage-gated, type IV, alpha, [Score=494, Expect=3e-155]; ENSMUSG00000075318, Scn2a, sodium channel, voltage-gated, type II, alpha, [Score=490, Expect=4e-153]; ENSMUSG00000057182, Scn3a, sodium channel, voltage-gated, type III, alpha, [Score=484, Expect=2e-151]; ENSMUSG00000075316, Scn9a, sodium channel, voltage-gated, type IX, alpha, [Score=484, Expect=4e-151]; ENSMUSG00000032511, Scn5a, sodium channel, voltage-gated, type V, alpha, [Score=483, Expect=1e-150]; ENSMUSG00000023033, Scn8a, sodium channel, voltage-gated, type VIII, alpha, [Score=481, Expect=5e-150]; ENSMUSG00000034533, Scn10a, sodium channel, voltage-gated, type X, alpha, [Score=475, Expect=6e-148]} {Dmel: FBgn0285944, para, paralytic, [Score=538, Expect=2e-170]} {Celegans: WBGene00001187, egl-19, Voltage-dependent L-type calcium channel subunit alpha, [Score=189, Expect=6e-50]} {Smed: dd_Smed_v6_13973_0_1, dd_Smed_v6_13973_0_1, [Score=610, Expect=0.0]} {RNA1509_56147} {RNA1310_51142} Mlig455_000489 {REF} {Length: 2384} {Pfam: Ion transport protein [PF00520.33, score=296.0]; Voltage-dependent L-type calcium channel, IQ-associated [PF16905.7, score=31.7]; Polycystin cation channel [PF08016.14, score=23.0]} {Human: ENSG00000144285, SCN1A, sodium voltage-gated channel alpha subunit 1, [Score=504, Expect=4e-157]; ENSG00000136531, SCN2A, sodium voltage-gated channel alpha subunit 2, [Score=501, Expect=2e-156]; ENSG00000169432, SCN9A, sodium voltage-gated channel alpha subunit 9, [Score=492, Expect=9e-153]; ENSG00000183873, SCN5A, sodium voltage-gated channel alpha subunit 5, [Score=489, Expect=1e-151]; ENSG00000153253, SCN3A, sodium voltage-gated channel alpha subunit 3, [Score=488, Expect=2e-151]; ENSG00000196876, SCN8A, sodium voltage-gated channel alpha subunit 8, [Score=483, Expect=9e-150]; ENSG00000007314, SCN4A, sodium voltage-gated channel alpha subunit 4, [Score=482, Expect=8e-150]; ENSG00000185313, SCN10A, sodium voltage-gated channel alpha subunit 10, [Score=479, Expect=4e-148]} {Mouse: ENSMUSG00000064329, Scn1a, sodium channel, voltage-gated, type I, alpha, [Score=502, Expect=1e-156]; ENSMUSG00000001027, Scn4a, sodium channel, voltage-gated, type IV, alpha, [Score=496, Expect=3e-155]; ENSMUSG00000075318, Scn2a, sodium channel, voltage-gated, type II, alpha, [Score=493, Expect=2e-153]; ENSMUSG00000075316, Scn9a, sodium channel, voltage-gated, type IX, alpha, [Score=487, Expect=4e-151]; ENSMUSG00000032511, Scn5a, sodium channel, voltage-gated, type V, alpha, [Score=486, Expect=1e-150]; ENSMUSG00000057182, Scn3a, sodium channel, voltage-gated, type III, alpha, [Score=486, Expect=4e-151]; ENSMUSG00000023033, Scn8a, sodium channel, voltage-gated, type VIII, alpha, [Score=483, Expect=6e-150]; ENSMUSG00000034533, Scn10a, sodium channel, voltage-gated, type X, alpha, [Score=478, Expect=7e-148]} {Dmel: FBgn0285944, para, paralytic, [Score=541, Expect=1e-170]} {Celegans: WBGene00001187, egl-19, Voltage-dependent L-type calcium channel subunit alpha, [Score=191, Expect=5e-50]} {Smed: dd_Smed_v6_14386_0_1, dd_Smed_v6_14386_0_1, [Score=627, Expect=0.0]} {RNA1509_56147} {RNA1310_51142} Mlig455_000526 {REF} {Length: 2384} {Pfam: Ion transport protein [PF00520.33, score=296.7]; Voltage-dependent L-type calcium channel, IQ-associated [PF16905.7, score=31.7]; Polycystin cation channel [PF08016.14, score=22.9]} {Human: ENSG00000144285, SCN1A, sodium voltage-gated channel alpha subunit 1, [Score=503, Expect=3e-157]; ENSG00000136531, SCN2A, sodium voltage-gated channel alpha subunit 2, [Score=501, Expect=2e-156]; ENSG00000169432, SCN9A, sodium voltage-gated channel alpha subunit 9, [Score=492, Expect=8e-153]; ENSG00000183873, SCN5A, sodium voltage-gated channel alpha subunit 5, [Score=489, Expect=8e-152]; ENSG00000153253, SCN3A, sodium voltage-gated channel alpha subunit 3, [Score=488, Expect=2e-151]; ENSG00000196876, SCN8A, sodium voltage-gated channel alpha subunit 8, [Score=484, Expect=1e-149]; ENSG00000007314, SCN4A, sodium voltage-gated channel alpha subunit 4, [Score=483, Expect=6e-150]; ENSG00000185313, SCN10A, sodium voltage-gated channel alpha subunit 10, [Score=478, Expect=5e-148]} {Mouse: ENSMUSG00000064329, Scn1a, sodium channel, voltage-gated, type I, alpha, [Score=502, Expect=1e-156]; ENSMUSG00000001027, Scn4a, sodium channel, voltage-gated, type IV, alpha, [Score=496, Expect=3e-155]; ENSMUSG00000075318, Scn2a, sodium channel, voltage-gated, type II, alpha, [Score=493, Expect=3e-153]; ENSMUSG00000075316, Scn9a, sodium channel, voltage-gated, type IX, alpha, [Score=487, Expect=4e-151]; ENSMUSG00000057182, Scn3a, sodium channel, voltage-gated, type III, alpha, [Score=486, Expect=4e-151]; ENSMUSG00000032511, Scn5a, sodium channel, voltage-gated, type V, alpha, [Score=486, Expect=2e-150]; ENSMUSG00000023033, Scn8a, sodium channel, voltage-gated, type VIII, alpha, [Score=484, Expect=5e-150]; ENSMUSG00000034533, Scn10a, sodium channel, voltage-gated, type X, alpha, [Score=478, Expect=7e-148]} {Dmel: FBgn0285944, para, paralytic, [Score=541, Expect=1e-170]} {Celegans: WBGene00001187, egl-19, Voltage-dependent L-type calcium channel subunit alpha, [Score=191, Expect=6e-50]} {Smed: dd_Smed_v6_14386_0_1, dd_Smed_v6_14386_0_1, [Score=628, Expect=0.0]} {RNA1509_56147} {RNA1310_51142} Mlig455_024858 {REF} {Length: 1954} {Pfam: Ion transport protein [PF00520.33, score=318.3]; Voltage-dependent L-type calcium channel, IQ-associated [PF16905.7, score=32.1]; Polycystin cation channel [PF08016.14, score=30.0]} {Human: ENSG00000144285, SCN1A, sodium voltage-gated channel alpha subunit 1, [Score=660, Expect=0.0]; ENSG00000136531, SCN2A, sodium voltage-gated channel alpha subunit 2, [Score=654, Expect=0.0]; ENSG00000169432, SCN9A, sodium voltage-gated channel alpha subunit 9, [Score=649, Expect=0.0]; ENSG00000183873, SCN5A, sodium voltage-gated channel alpha subunit 5, [Score=640, Expect=0.0]; ENSG00000153253, SCN3A, sodium voltage-gated channel alpha subunit 3, [Score=639, Expect=0.0]; ENSG00000007314, SCN4A, sodium voltage-gated channel alpha subunit 4, [Score=635, Expect=0.0]; ENSG00000196876, SCN8A, sodium voltage-gated channel alpha subunit 8, [Score=631, Expect=0.0]; ENSG00000185313, SCN10A, sodium voltage-gated channel alpha subunit 10, [Score=627, Expect=0.0]} {Mouse: ENSMUSG00000064329, Scn1a, sodium channel, voltage-gated, type I, alpha, [Score=655, Expect=0.0]; ENSMUSG00000001027, Scn4a, sodium channel, voltage-gated, type IV, alpha, [Score=652, Expect=0.0]; ENSMUSG00000075318, Scn2a, sodium channel, voltage-gated, type II, alpha, [Score=646, Expect=0.0]; ENSMUSG00000075316, Scn9a, sodium channel, voltage-gated, type IX, alpha, [Score=645, Expect=0.0]; ENSMUSG00000057182, Scn3a, sodium channel, voltage-gated, type III, alpha, [Score=637, Expect=0.0]; ENSMUSG00000032511, Scn5a, sodium channel, voltage-gated, type V, alpha, [Score=635, Expect=0.0]; ENSMUSG00000023033, Scn8a, sodium channel, voltage-gated, type VIII, alpha, [Score=630, Expect=0.0]; ENSMUSG00000034533, Scn10a, sodium channel, voltage-gated, type X, alpha, [Score=623, Expect=0.0]} {Dmel: FBgn0285944, para, paralytic, [Score=701, Expect=0.0]} {Celegans: WBGene00001187, egl-19, Voltage-dependent L-type calcium channel subunit alpha, [Score=268, Expect=3e-77]} {Smed: dd_Smed_v6_14386_0_1, dd_Smed_v6_14386_0_1, [Score=816, Expect=0.0]} {RNA1310_51142} |
| 12. | MligTC455_21050 | 18 | 0.37 | Mlig455_024510 | Neo: - Age: - |
0.967 | - | - | - | - | 0.967 | - | Mlig455_024510 {REF} {Length: 2499} {RNA1310_68107} {RNA815_59638} | |
| 13. | MligTC455_54274 | 117 | 2.44 | Mlig455_027010 | Neo: - Age: - |
0.964 | - | - | - | - | 0.964 | - | Mlig455_027010 {REF} {Length: 1490} {Pfam: Cornifin (SPRR) family [PF02389.17, score=31.2]} {Mouse: ENSMUSG00000048455, Sprr1b, small proline-rich protein 1B, [Score=42.7, Expect=1e-05]} {RNA1509_43344, RNA1509_49957} {RNA1310_7447.1, RNA1509_49957} {RNA1509_49957, RNA815_1983} | |
| 14. | MligTC455_22613 | 61 | 1.28 | Mlig455_027104 | Neo: - Age: - |
FYN | 0.962 | - | - | - | - | 0.962 | - | Mlig455_027104 {REF} {Length: 3199} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=253.8]; Protein kinase domain [PF00069.27, score=164.0]; SH3 domain [PF00018.30, score=35.8]; Variant SH3 domain [PF07653.19, score=34.4]; SH2 domain [PF00017.26, score=33.0]; Variant SH3 domain [PF14604.8, score=30.8]; Bacterial SH3 domain [PF08239.13, score=24.5]; Kinase-like [PF14531.8, score=18.6]; ABC1 atypical kinase-like domain [PF03109.18, score=18.3]} {Human: ENSG00000010810, FYN, FYN proto-oncogene, Src family tyrosine kinase, [Score=280, Expect=6e-87]; ENSG00000101336, HCK, HCK proto-oncogene, Src family tyrosine kinase, [Score=274, Expect=6e-85]; ENSG00000182866, LCK, LCK proto-oncogene, Src family tyrosine kinase, [Score=272, Expect=2e-84]; ENSG00000254087, LYN, LYN proto-oncogene, Src family tyrosine kinase, [Score=268, Expect=6e-83]} {Mouse: ENSMUSG00000019843, Fyn, Fyn proto-oncogene, [Score=280, Expect=5e-87]; ENSMUSG00000000409, Lck, lymphocyte protein tyrosine kinase, [Score=276, Expect=6e-86]; ENSMUSG00000042228, Lyn, LYN proto-oncogene, Src family tyrosine kinase, [Score=269, Expect=2e-83]; ENSMUSG00000014932, Yes1, YES proto-oncogene 1, Src family tyrosine kinase, [Score=266, Expect=7e-82]} {Dmel: FBgn0262733, Src64B, Src oncogene at 64B, [Score=271, Expect=6e-84]} {Celegans: WBGene00005077, src-1, Tyrosine protein-kinase src-1, [Score=278, Expect=2e-87]} {Smed: dd_Smed_v6_3363_0_1, dd_Smed_v6_3363_0_1, [Score=313, Expect=8e-101]} {RNA1509_37079} {RNA1310_14637} {RNA815_4860} |
| 15. | MligTC455_00431 | 10 | 0.21 | Mlig455_062910 | Neo: - Age: - |
0.961 | - | - | - | - | 0.961 | - | Mlig455_062910 {REF} {Length: 862} {RNA1509_15401} {RNA1310_104073} {RNA815_6960} | |
| 16. | MligTC455_27968 | 139 | 2.9 | Mlig455_006102 | Neo: - Age: - |
SYNCRIP | 0.961 | - | - | - | - | 0.961 | - | Mlig455_006102 {REF} {Length: 3069} {TRANSSPLICED} {Pfam: RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) [PF00076.24, score=86.6]; Double-stranded RNA binding motif [PF00035.28, score=67.2]; Occluded RNA-recognition motif [PF16842.7, score=20.3]} {Human: ENSG00000135316, SYNCRIP, synaptotagmin binding cytoplasmic RNA interacting protein, [Score=189, Expect=7e-52]} {Mouse: ENSMUSG00000032423, Syncrip, synaptotagmin binding, cytoplasmic RNA interacting protein, [Score=188, Expect=1e-51]} {Dmel: FBgn0038826, Syp, Syncrip, [Score=223, Expect=4e-63]} {Celegans: WBGene00015943, tiar-1, TIA-1/TIAL RNA binding protein homolog, [Score=63.9, Expect=2e-10]} {Smed: dd_Smed_v6_62256_0_1, dd_Smed_v6_62256_0_1, [Score=144, Expect=4e-37]} {RNA1509_30609} {RNA1310_8624} {RNA815_8285} |
| 17. | MligTC455_47805 | 309 | 6.43 | Mlig455_002866, Mlig455_033201 | Neo: - |
NR2C2 | 0.961 | - | - | - | - | 0.961 | - | Mlig455_002866 {REF} {Length: 2397} {RNA1509_25172} {RNA1310_17963.1} {RNA815_11681} Mlig455_033201 {REF} {Length: 2405} {Pfam: Zinc finger, C4 type (two domains) [PF00105.20, score=86.4]} {Human: ENSG00000177463, NR2C2, nuclear receptor subfamily 2 group C member 2, [Score=90.5, Expect=1e-18]; ENSG00000120798, NR2C1, nuclear receptor subfamily 2 group C member 1, [Score=87.8, Expect=4e-18]; ENSG00000101076, HNF4A, hepatocyte nuclear factor 4 alpha, [Score=87.4, Expect=7e-18]; ENSG00000113580, NR3C1, nuclear receptor subfamily 3 group C member 1, [Score=87.4, Expect=2e-17]; ENSG00000175745, NR2F1, nuclear receptor subfamily 2 group F member 1, [Score=87.0, Expect=6e-18]; ENSG00000160113, NR2F6, nuclear receptor subfamily 2 group F member 6, [Score=86.7, Expect=9e-18]; ENSG00000151623, NR3C2, nuclear receptor subfamily 3 group C member 2, [Score=86.7, Expect=3e-17]} {Mouse: ENSMUSG00000005893, Nr2c2, nuclear receptor subfamily 2, group C, member 2, [Score=88.2, Expect=5e-18]; ENSMUSG00000017950, Hnf4a, hepatic nuclear factor 4, alpha, [Score=88.2, Expect=3e-18]; ENSMUSG00000069171, Nr2f1, nuclear receptor subfamily 2, group F, member 1, [Score=87.0, Expect=5e-18]; ENSMUSG00000031618, Nr3c2, nuclear receptor subfamily 3, group C, member 2, [Score=87.0, Expect=1e-17]; ENSMUSG00000005897, Nr2c1, nuclear receptor subfamily 2, group C, member 1, [Score=86.7, Expect=1e-17]; ENSMUSG00000002393, Nr2f6, nuclear receptor subfamily 2, group F, member 6, [Score=85.9, Expect=9e-18]; ENSMUSG00000030551, Nr2f2, nuclear receptor subfamily 2, group F, member 2, [Score=85.1, Expect=2e-17]; ENSMUSG00000023034, Nr4a1, nuclear receptor subfamily 4, group A, member 1, [Score=85.1, Expect=4e-17]; ENSMUSG00000024431, Nr3c1, nuclear receptor subfamily 3, group C, member 1, [Score=85.1, Expect=5e-17]; ENSMUSG00000026398, Nr5a2, nuclear receptor subfamily 5, group A, member 2, [Score=84.3, Expect=7e-17]} {Dmel: FBgn0264562, Hr4, Hormone receptor 4, [Score=96.3, Expect=1e-20]} {Celegans: WBGene00003681, nhr-91, Nuclear hormone receptor family member nhr-91, [Score=89.7, Expect=5e-19]} {Smed: dd_Smed_v6_33286_0_2, dd_Smed_v6_33286_0_2, [Score=86.7, Expect=6e-19]} {RNA1509_25172} {RNA1310_17963.1, RNA1509_25172} {RNA1509_25172, RNA815_11681} |
| 18. | MligTC455_27969 | 203 | 4.24 | Mlig455_055219, Mlig455_055313 | Neo: - Age: - |
ADARB1 | 0.958 | - | - | - | - | 0.958 | - | Mlig455_055219 {REF} {Length: 3087} {TRANSSPLICED} {Pfam: Adenosine-deaminase (editase) domain [PF02137.20, score=288.8]; Double-stranded RNA binding motif [PF00035.28, score=44.8]} {Human: ENSG00000197381, ADARB1, adenosine deaminase, RNA specific B1, [RH, Score=346, Expect=9e-110]} {Mouse: ENSMUSG00000020262, Adarb1, adenosine deaminase, RNA-specific, B1, [RH, Score=358, Expect=3e-114]} {Dmel: FBgn0026086, Adar, Adenosine deaminase acting on RNA, [RH, Score=296, Expect=2e-91]} {Celegans: WBGene00000080, adr-2, Probable double-stranded RNA-specific adenosine deaminase, [RH, Score=184, Expect=2e-51]} {Smed: dd_Smed_v6_4538_0_1, dd_Smed_v6_4538_0_1, [RH, Score=235, Expect=5e-68]} {RNA1509_57256} {RNA1310_8624} {RNA815_8285} Mlig455_055313 {REF} {Length: 2868} {TRANSSPLICED} {Pfam: Adenosine-deaminase (editase) domain [PF02137.20, score=289.4]; Double-stranded RNA binding motif [PF00035.28, score=44.8]} {Human: ENSG00000197381, ADARB1, adenosine deaminase, RNA specific B1, [RH, Score=347, Expect=5e-110]} {Mouse: ENSMUSG00000020262, Adarb1, adenosine deaminase, RNA-specific, B1, [RH, Score=356, Expect=1e-113]} {Dmel: FBgn0026086, Adar, Adenosine deaminase acting on RNA, [RH, Score=290, Expect=8e-89]} {Celegans: WBGene00000080, adr-2, Probable double-stranded RNA-specific adenosine deaminase, [RH, Score=184, Expect=3e-51]} {Smed: dd_Smed_v6_4538_0_1, dd_Smed_v6_4538_0_1, [RH, Score=236, Expect=3e-68]} {RNA1509_57256, RNA1509_57608} {RNA1310_8624, RNA1509_57256, RNA1509_57608} {RNA1509_57256, RNA1509_57608, RNA815_8285} |
| 19. | MligTC455_37483 | 65 | 1.35 | Mlig455_039434 | Neo: - Age: Down-Up-Down Regeneration-enriched R4: 9.467 |
0.954 | - | - | - | - | 0.954 | - | Mlig455_039434 {REF} {Length: 5360} {RNA1310_7246} {RNA815_26161} | |
| 20. | MligTC455_47819 | 9 | 0.2 | Mlig455_033339, Mlig455_059759 | Neo: - Age: - |
0.954 | - | - | - | - | 0.954 | - | Mlig455_033339 {REF} {Length: 1057} {RNA1509_48033} {RNA1310_58376} {RNA815_51419} Mlig455_059759 {REF} {Length: 109} {NoTransDecoderORF} {RNA1310_58376} {RNA815_51419} |
|
| 21. | MligTC455_07305 | 45 | 0.94 | Mlig455_022055 | Neo: - Age: - |
0.953 | - | - | - | - | 0.953 | - | Mlig455_022055 {REF} {Length: 1195} {Mouse: ENSMUSG00000033088, Triobp, TRIO and F-actin binding protein, [Score=51.6, Expect=4e-07]} {Smed: dd_Smed_v6_1985_0_1, dd_Smed_v6_1985_0_1, [Score=53.1, Expect=5e-08]} | |
| 22. | MligTC455_00349 | 7 | 0.15 | Mlig455_069175 | Neo: - Age: - |
0.952 | - | - | - | - | 0.952 | - | Mlig455_069175 {REF} {Length: 639} {RNA1310_21320} | |
| 23. | MligTC455_18550 | 27 | 0.57 | Mlig455_003630 | Neo: Germline Age: logFC(26M/2M)=-0.849 |
0.952 | - | - | - | - | 0.952 | - | Mlig455_003630 {REF} {Length: 2511} {RNA1509_32165} {RNA1310_13450} {RNA815_5462.1} | |
| 24. | MligTC455_17225 | 6 | 0.12 | Mlig455_039944 | Neo: - Age: - |
0.95 | - | - | - | - | 0.950 | - | Mlig455_039944 {REF} {Length: 436} {NoTransDecoderORF} {RNA1509_58333} {RNA1310_7959.1} {RNA815_41251} | |
| 25. | MligTC455_20910 | 10 | 0.22 | Mlig455_039653 | Neo: - Age: - |
0.95 | - | - | - | - | 0.950 | - | Mlig455_039653 {REF} {Length: 1234} {RNA1509_48033} {RNA1310_47692} {RNA815_51419} |